1). Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin N Am. 2011; 95:87–100.
Article
2). Bosch JL, Cardozo L, Hashim H, Hilton P, Oelke M, Robinson D. Constructing trials to show whether urodynamic studies are necessary in lower urinary tract dysfunction. Neurourol Urodyn. 2011; 30:735–40.
Article
3). Klausner AP, Steers WD. The neurogenic bladder: an update with management strategies for primary care physicians. Med Clin North Am. 2011; 95:111–20.
Article
4). Rule AD, Lieber MM, Jacobsen SJ. Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol. 2005; 173:691–6.
Article
5). Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. International Continence Society. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002; 21:261–74.
Article
6). Radley SC, Rosario DJ, Chapple CR, Farkas AG. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. J Urol. 2001; 166:2253–8.
Article
7). Corona-Quintanilla DL, Castelán F, Fajardo V, Manzo J, Martínez-Gómez M. Temporal coordination of pel-vic and perineal striated muscle activity during micturition in female rabbits. J Urol. 2009; 181:1452–8.
Article
8). Fletter PC, Majerus S, Cong P, Damaser MS, Ko WH, Young DJ, et al. Wireless micromanometer system for chronic bladder pressure monitoring. The 6th International Conference on Networked Sensing System, Pittsburgh, USA. 2009. 228–31.
Article
9). Kadhiresan K, Carlson G. The role of implantable sensors for management of heart failure. Stud Health Technol Inform. 2004; 108:219–27.
10). Renard E. Implantable continuous glucose sensors. Curr Diabetes Rev. 2008; 4:169–74.
Article
11). Renard E, Costalat G, Chevassus H, Bringer J. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab. 2006; 32:497–502.
12). Hao Y, Foster R. Wireless body sensor networks for health-monitoring applications. Physiol Meas. 2008; 29:R27–56.
Article
13). Kakaday T, Hewitt AW, Voelcker NH, Li JS, Craig JE. Advances in telemetric continuous intraocular pressure assessment. Br J Ophthalmol. 2009; 93:992–6.
Article
14). Seif C, Herberger B, Cherwon E, Martinez Portillo FJ, Molitor M, Stieglitz T, et al. Urinary bladder volumetry by means of a single retrosymphysically implantable ultrasound unit. Neurourol Urodyn. 2004; 23:680–4.
Article
15). Young DJ. Wireless micromanometer system for chronic bladder pressure monitoring. The 5th IEEE International Conference on Nano/Micro engineered and Molecular Systems, Xiamen, China. 2010. 604–7.
16). Lee DS, Kim SJ, Sohn DW, Yoo JM, Choi BK, Lee MK, et al. Measurement of bladder volume using an implantable volume sensor in rats. Korean J Androl. 2010; 28:169–74.
17). Bates CP, Whiteside CG, Turner-Warwick R. Synchronous cine-pressure-flow-cysto-urethrography with special reference to stress and urge incontinence. Br J Urol. 1970; 42:714–23.
Article
18). Gorton E, Stanton S. Women's attitudes to urodynamics: a questionnaire survey. Br J Obstet Gynaecol. 1999; 106:851–6.
Article
19). Webb RJ, Ramsden PD, Neal DE. Ambulatory monitoring and electronic measurement of urinary leakage in the diagnosis of detrusor instability and incontinence. Br J Urol. 1991; 68:148–52.
Article
20). Heslington K, Hilton P. Ambulatory monitoring and conventional cystometry in asymptomatic female volunteers. Br J Obstet Gynaecol. 1996; 103:434–41.
Article
21). Mills IW, Noble JG, Brading AF. Radiotelemetered cystometry in pigs: validation and comparison of natural filling versus diuresis cystometry. J Urol. 2000; 164:1745–50.
Article
22). Shaw MB, Herndon CD, Cain MP, Rink RC, Kaefer M. A porcine model of bladder outlet obstruction incorporating radio-telemetered cystometry. BJU Int. 2007; 100:170–4.
Article
23). Tan R, McClure T, Lin CK, Jea D, Dabiri F, Massey T, et al. Development of a fully implantable wireless pressure monitoring system. Biomed Microdevices. 2009; 11:259–64.
Article